Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00146003 · ClinicalTrials.gov registry record · Phase 2
Efalizumab for Eczema
A Phase 2 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00146003 is a Phase 2 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 10 participants.
The verdict
NCT00146003, a Phase 2 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate a measurable improvement on a validated scale in a small population of adult patients with atopic dermatitis (eczema).
Interventions
- DRUG Efalizumab treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00146003
The ClinicalTrials.gov registry entry for NCT00146003 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Efalizumab treatment is the first listed.
NCT00146003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00146003 about?
NCT00146003 is a clinical study titled "Efalizumab for Eczema". The purpose of this study is to demonstrate a measurable improvement on a validated scale in a small population of adult patients with atopic dermatitis (eczema).
What is the current status of trial NCT00146003?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2005-03. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00146003?
The interventions under investigation include: Efalizumab treatment (DRUG).
Who is sponsoring clinical trial NCT00146003?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.